Singapore Clinical Trial: A Phase 1 randomized, placebo-controlled multiple dose study to characterize the effects of LY4088182 on renal hemodynamics in participants with overweight or obesity.

Posted On: 2026-03-27

Singapore, March 27 -- The Health Sciences Authority received information related to the study titled 'A Phase 1 randomized, placebo-controlled multiple dose study to characterize the effects of LY4088182 on renal hemodynamics in participants with overweight or obesity.'. The following are the other relevant details related to the trial:

Therapeutic Area: Endocrinology & Metabolism

Trial Centre(s): Lilly Centre for Pharmacology

Trial Status: NA

Principal Investigator(s): Dr Jennifer Lua Boon Wee

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Singapore Clinical Trial: A Phase 1 randomized, placebo-controlled multiple dose study to characterize the effects of LY4088182 on renal hemodynamics in participants with overweight or obesity.